Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eyegate Pharmaceuticals Inc. EYEGV

Healthcare Biotechnology


GREY:EYEGV - Post by User

Eyegate Pharmaceuticals Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(291)
•••
Post by whytestockson Jun 14, 2023 2:30pm
91 Views
Post# 35496499

Kiora Pharmaceuticals to Present at Upcoming Investor Confer

Kiora Pharmaceuticals to Present at Upcoming Investor Confer
NEWS: $KPRX Kiora Pharmaceuticals to Present at Upcoming Investor ConferencesEncinitas, California--(Newsfile Corp. - June 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced its President &amp; CEO, Brian Strem, Ph.D., will participate in two upcoming investor conferences. The Healthcare Virtual Conference hosted by Maxim Group June 20, 2023 from 10:00 t...KPRX - Kiora Pharmaceuticals to Present at Upcoming Investor Conferences

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities